RASSF1 and breast cancer: For example, hypermethylation of RASSF1A can be used to detect breast cancer during the early stages using a CpG island that is hypermethylated in 60–70% of breast cancers [10, 11] or a promoter that is hypermethylated in 70% of breast cancer individuals [12].